Please login to the form below

Not currently logged in
Email:
Password:

Shire backs campaign for ADHD support

Ireland-based pharmaceutical company Shire is supporting a European campaign to increase awareness and support for ADHD in schools as part of ADHD Awareness Week

Ireland-based pharmaceutical company Shire is supporting a European campaign to increase awareness and support for attention deficit hyperactivity disorder (ADHD) in schools as part of ADHD Awareness Week.

Stakeholders in ADHD working in policy, education and advocacy across Europe discussed methods to improve understanding and acceptance of the condition at a meeting held in Brussels, Belgium.

Delegates agreed the relationship between parents and teachers was integral to the success of any support plan and advised on four aims to help achieve their goal:

• More services and tools to help parents and teachers work together to manage the needs of a child with ADHD in the school setting effectively
• Better ADHD education for teachers to help them identify and manage the condition
• More support networks to help parents and patients with ADHD
• Greater recognition and prioritisation of ADHD in health services to improve diagnosis and management.

As part of the call for improved action, Shire, in collaboration with not-for-profit organisation ADHD Europe, launched the ADHD Partnership Support Pack - an online toolkit to help parents, carers and teachers support children with ADHD.

ADHD has an estimated global cost of $31.5bn a year, according to Shire.

28th September 2011

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics